ISRG vs. ABT, SYK, BSX, MDT, BDX, EW, IDXX, RMD, DXCM, and STE
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Stryker (SYK), Boston Scientific (BSX), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Intuitive Surgical vs.
Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, institutional ownership, media sentiment, valuation and risk.
Abbott Laboratories currently has a consensus target price of $130.71, indicating a potential upside of 14.43%. Intuitive Surgical has a consensus target price of $554.17, indicating a potential upside of 5.67%. Given Abbott Laboratories' higher probable upside, research analysts plainly believe Abbott Laboratories is more favorable than Intuitive Surgical.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Abbott Laboratories had 7 more articles in the media than Intuitive Surgical. MarketBeat recorded 15 mentions for Abbott Laboratories and 8 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 0.88 beat Abbott Laboratories' score of 0.84 indicating that Intuitive Surgical is being referred to more favorably in the news media.
Abbott Laboratories has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500.
75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 1.1% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.9% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Intuitive Surgical received 110 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.70% of users gave Abbott Laboratories an outperform vote while only 69.09% of users gave Intuitive Surgical an outperform vote.
Intuitive Surgical has a net margin of 28.51% compared to Abbott Laboratories' net margin of 13.99%. Abbott Laboratories' return on equity of 20.18% beat Intuitive Surgical's return on equity.
Summary
Intuitive Surgical beats Abbott Laboratories on 11 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
Related Companies and Tools
This page (NASDAQ:ISRG) was last updated on 12/21/2024 by MarketBeat.com Staff
Free ISRG Stock Alerts